Objectives To assess among pregnant and recently delivered women the timing of thinking about and seeking information about childhood vaccines and the preferred modes of vaccine education.
In 2013, the American Academy of Arts and Sciences convened a conference of experts in parental vaccine hesitancy in 2013 to outline a research agenda to address this growing problem. 9 The group's conclusion was that research is needed to address how and when attitudes and beliefs about vaccines are formed, how parents make decisions about vaccination, and how to best present information about vaccines to hesitant parents. Therefore, to address these questions, the objectives of this study were to assess among pregnant and recently delivered women (1) the timing of thinking about and seeking information about infant vaccines and (2) preferred modes of communication about infant vaccines.
Methods
From January to February 2014, an e-mail survey was administered to the 425 eligible women identified. All study participants were patients at 1 of 9 obstetrics/ gynecology (OB/GYN) practices (6 urban, 3 rural) in Colorado. Women were eligible for the study if they had agreed to be contacted for a follow-up survey after completing a previous paper-based survey, provided a working e-mail address, and had an estimated date of delivery between January and March of 2014. The previous paper-based survey was used to measure general vaccination uptake of the patient populations of these 9 OB/GYN practices. This was a convenience sample administered in the reception areas of these practices, and included questions regarding pregnancy status and, if pregnant, date of delivery. The only demographic variable available for respondents to this previous survey was age. The survey for the present study was timed so that approximately one-half of the study population would be pregnant at the time of the study and the other one-half would have recently delivered. Consent for the survey was obtained with the invitation to participate in the survey. This study was approved by the Colorado Multi-Institutional Review Board.
Survey Design
The survey was designed to minimize bias regarding vaccines by asking about many other issues of possible concern to pregnant or recently delivered women. It was introduced with the following sentence: "Your obstetrics and gynecology (OB/ GYN) office is working with the University of Colorado School of Medicine on this survey. We want to understand patients' concerns during and after pregnancy." Demographic characteristics collected included age, education, race/ethnicity, household income, insurance type, and child's birthdate or estimated date of delivery. The next section of the survey was introduced with the following statement: "In this section, we are going to ask you 2 sets of questions. The first set of questions is about your thoughts, and the second set is about your actions. Over the last couple of weeks, please tell us how often you have been thinking about each of the following." They were then provided with a list of potential concerns, including"my weight," "my diet," "my ability to breastfeed," "vaccinations for myself (such as influenza or pertussis),""vaccinations for my baby (the infant shot series of vaccines)," "child care for my baby," "illnesses I could catch and their effect on me," "illnesses I could catch and their effect on my baby," "illnesses my baby could catch,""my sleep,""my baby's sleep,""my baby's ability to gain weight,""financial issues that could affect my baby,""my mood," "going back to work when the time comes," "foods I eat that could affect my baby," and "medicines I take that might affect my baby." These were answered with responses on a 4-point Likert scale (often, sometimes, rarely, not at all). After answering these questions, respondents were directed to the following statement: "We would next like to understand which of the following you have been seeking information about. Over the last couple of weeks, please tells us how often you have looked for information about each of the following." This was followed by the same list of potential concerns. Results for the non-vaccine-related questions are available on request.
The next section of the survey assessed the acceptability and likelihood of use of various possible sources of vaccine information. The acceptability and likelihood of use were assessed on a 4-point Likert scale (very likely, somewhat likely, not very likely, not at all likely). Vaccine hesitancy was assessed with 2 questions from the Parent Attitudes About Childhood Vaccines (PACV) survey, a validated scale of vaccine hesitancy 10 : "How hesitant about childhood vaccines do you consider yourself?" and "How concerned are you that one of the childhood vaccines might not be safe?" These questions were taken verbatim from the PACV and were answered using a 5-point Likert scale, including a "not sure" response.
Survey Administration
The survey was administered by e-mail in English using Research Electronic Data Capture (REDCap). E-mail addresses were tested for validity before the survey was sent sending using the e-mail validation service Email-Checker.com. The Dillman methodology of survey administration was followed and modified to accommodate exclusively online administration. 11 We sent an introductory e-mail signed by office managers or physicians in the patients' OB/GYN practices informing the patient that a survey would be coming, followed by the survey link and an introductory letter 7 days later. An offer of a $5 gift card was included in this introductory e-mail and was sent electronically on completion of the survey. After the initial survey link and introductory e-mail, up to 7 e-mail reminders were sent to nonresponders, along with 1 reminder phone call for those nonrespondents who had provided a working phone number.
Statistical Analyses
Descriptive statistics were generated for all survey questions. The c 2 test of proportions or the Fisher exact test were used to compare characteristics and responses of women who had delivered and those who were pregnant, as well as women classified as hesitant and those who were nonhesitant. For stratified analyses, women were considered hesitant if they responded "somewhat hesitant" or "very hesitant" in response to the question, "How hesitant about childhood vaccines do you consider yourself?" The frequency of information-seeking was assessed in comparison with estimated or actual delivery date. All analyses were performed using SAS 9.4 (SAS Institute, Cary, North Carolina). A P value of < .05 was considered statistically significant.
Results
The response rate was 54% (230 of 425). There were no differences between responders and nonresponders with respect to age. Among respondents, 56% were pregnant and 44% had delivered. Among the pregnant respondents, 93% were in the third trimester of pregnancy (>28 weeks). The mean age of the study population was 30.8 years, 51% were first-time parents, 67% had a college or advanced degree, 75% were privately insured, 72% reported an annual household income of >$50 000, and 85% were non-Hispanic white (Table I) . Overall, 2% (n = 5) reported being "very hesitant" and 16% (n = 37) reported being "somewhat hesitant" about vaccines, and 19% (n = 44) reported being "somewhat concerned" and 8% (n = 18) reported being "very concerned" that at least 1 childhood vaccine might not be safe (Table II) . Although 45% (n = 103) of the study population considered themselves "not at all" vaccine-hesitant, only 26% (n = 60) reported being "not at all" concerned about vaccine safety.
Frequency of Thinking about Infant Vaccines
To the question asking about how often they thought about infant vaccines, overall, 24% of the women responded "often"; 46%, "sometimes"; 20%, "rarely"; and 11%, "not at all." Figure 1 illustrates the reported frequency of thinking about infant vaccines stratified by delivery status compared with self-reported level of thinking about maternal vaccines. Women who had THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 203 • December 2018 already delivered reported thinking about infant vaccines more often than women who were still pregnant, with 29% of women who had delivered reporting "often" and 51% reporting "sometimes" compared with 19% and 42%, respectively, of pregnant women (P < .05). These findings were consistent in the subset of vaccine-hesitant women as well (Appendix; available at www.jpeds.com), although the differences were not statistically significant (delivered: 44% often, 55% sometimes; pregnant: 26% often, 52% sometimes).
Frequency of Seeking Information about Infant Vaccines
Overall, 10% of women reported seeking information about infant vaccines "often," 27% responded "sometimes," 24% responded "rarely," and 38% responded "not at all." Similar to the frequency of thinking about infant vaccines, women who had delivered reported seeking information about infant vaccines more often than those who were pregnant (delivered: 16% "often," 34% "sometimes"; pregnant: 6% "often," 22% "sometimes"; P < .01) (Figure 1 ). This finding also was consistent in vaccine-hesitant participants, in whom "often" or "sometimes"' seeking vaccine information was more common after delivery (19% and 44%, respectively) than while still pregnant (9% and 26%, respectively; P = not significant) (Appendix). Figure 2 shows responses regarding seeking information about infant vaccines based on the expected or actual date of delivery. The highest rate of "often" or "sometimes" responses were from women at 2-4 weeks and 4-6 weeks after delivery. These periods also were the only ones during which there were more responses of "often" or "sometimes" compared with "rarely" or "not at all," meaning that more women with infants at these ages were often or sometimes seeking vaccine information than women who reported rarely or not at all seeking vaccine information.
Sources of Information about Childhood Vaccines
Overall, most women preferred a conversation with their child's doctor compared with other sources of childhood vaccine information (Figure 3) , with 95% of women reporting this as a "very acceptable" source of information, and 92% responding that this is a source they are "very likely" to use. Most women also were amenable to conversations and information about childhood vaccines from their obstetrician. More than one-half of women reported being likely to use webbased information provided by either their obstetrician or their child's doctor. Other sources of information, such as books, newspapers, or magazines and websites suggested by family and friends, were favored less often. There were no significant differences in these responses between pregnant and recently delivered women or between hesitant and nonhesitant respondents.
Discussion
This study provides new insights into maternal informationseeking preferences regarding early childhood vaccination. We found that that pregnant and recently delivered women frequently think about and seek information about childhood vaccines, and this finding was true both for vaccine-hesitant and -nonhesitant women. We also found that these behaviors tend to occur more frequently in the period shortly after delivery (from about 2 weeks to 6 weeks) than before delivery, which is in contrast to previous reports. 5, 12 Pregnant women also tend to report thinking more about and seeking information about the infant series of vaccines than about vaccines for themselves, such as influenza or pertussis. Finally, consistent with previous reports, 3, 13, 14 we found that the most favored source of vaccine-related information is a child's doctor, but that most women also are amenable to conversations and information from their obstetrician, and are also amenable to web-based information from either source. Our findings of more frequent information-seeking about vaccines after delivery complement several previous investigations on the subject. Vannice et al asked about preferences for when to receive vaccine-related information from women receiving information prenatally, at a 1-week well child visit, or at a 2-month well child visit and found that the women generally preferred receiving information at a visit before a potential vaccination visit or at a prenatal visit rather than immediately before vaccination, 15 a finding essentially consistent with our data.
The findings reported in other studies may appear to conflict with our present results, however. A study among postpartum mothers in Connecticut reported that 70% of survey respondents preferred receiving information about vaccination before or during pregnancy and 20% preferred it during their baby's first month of life, in apparent contrast to our findings. 12 In a mixed-methods study, Glanz et al convened focus groups among vaccine-hesitant parents, then administered a quantitative survey among parents who had delayed, refused, or accepted vaccines for their children. 5 The qualitative portion of the study showed that in vaccine-hesitant parents, the vaccine decision-making process began in pregnancy. Among the survey respondents, 87% of refusers, 76% of delayers, and 64% of acceptors reported starting thinking about vaccines before their child was born. However, both of the foregoing studies were retrospective, conducted among parents of young children, whereas we report actual information-seeking behavior. Those other studies also reported preferences and not actions and, in the Glanz study, when parents had starting thinking about vaccines, not considering the frequency of thinking. Recognizing these differences in study design, our study complements these previous studies. We do not suggest that women *P < .05 **P < .01 should not be offered vaccine information during pregnancyindeed, they should, based on the findings from the previous studies. Our work suggests that along with offering information about vaccination during pregnancy, providing accurate information after delivery may reach the most women and have the most impact. This time window should be evaluated further as an opportunity for providing education to new parents.
This study has several strengths and limitations. It provides an innovative, near real-time description of the timing of information-seeking about childhood vaccines among pregnant women and mothers of newborns. Recall bias was reduced by asking the women to report their thoughts and actions over the previous 2 weeks, rather than in more distant retrospect. In addition, questions about vaccination were embedded into a larger survey, further reducing bias. However, the majority of respondents were Caucasian, highly educated, and privately insured. Our results might not be generalizable to women of other demographics, and as such, future work should examine these questions in other settings, including public settings. We also used a shortened version of the Parental Attitudes About Childhood Vaccination (PACV) Scale. It is possible that some respondents were misclassified, given that the PACV was validated based on longer versions of the survey. Moreover, there were fewer respondents in the tails of the time distribution surrounding date of delivery, and so conclusions about these women earlier in pregnancy or more distant from delivery should be interpreted with caution. We also had a limited sample size and so were unable to analyze potentially important differences in certain variables, such as differences between first-time parents and parents with older children. Finally, although we achieved a relatively high response rate, our survey respondents may differ from nonrespondents in important ways, and we had limited information on nonrespondents.
Future interventions to address maternal vaccine hesitancy should consider the time shortly after delivery as the optimal window for providing vaccine-related information. Even in mothers who are not vaccine-hesitant, this period also seems crucial for providing accurate vaccine-related information. Although the baby's doctor is the most preferred source of childhood vaccine information, obstetric providers should consider providing such information in their offices, for example at the postpartum visit, which would correspond with this time frame. Web-based information sent from the *Larger bubbles represent more responses provider's office appears to be acceptable to most women and thus should be considered in future interventions. In addition, investigators in this field should consider replicating this work in more diverse populations with a larger sample size. ■
